HEADER TRANSLOCASE 16-JAN-20 6XTE TITLE HUMAN KARYOPHERIN RANBP5 (ISOFORM-1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMPORTIN-5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IMP5,IMPORTIN SUBUNIT BETA-3,KARYOPHERIN BETA-3,RAN-BINDING COMPND 5 PROTEIN 5,RANBP5; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: CSO-893 CORRESPONDS TO AN OXYDAZED FORM OF THE CYS- COMPND 8 893; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ANTIPAIN; COMPND 11 CHAIN: C SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IPO5, KPNB3, RANBP5; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: ACTINOMYCETIA; SOURCE 11 ORGANISM_TAXID: 1760 KEYWDS HUMAN KARYOPHERIN, PA-PB1 SUB-COMPLEX NUCLEAR IMPORT, INFLUENZA KEYWDS 2 POLYMERASE ASSEMBLY, HOST-PATHOGEN INTERACTION, TRANSLOCASE EXPDTA X-RAY DIFFRACTION AUTHOR C.SWALE,A.A.MCCARTHY,R.W.H.RUIGROK,T.CREPIN REVDAT 4 31-JAN-24 6XTE 1 REMARK REVDAT 3 07-DEC-22 6XTE 1 COMPND SOURCE REMARK DBREF REVDAT 3 2 1 SEQRES HET HETNAM FORMUL REVDAT 3 3 1 LINK SITE ATOM REVDAT 2 27-MAY-20 6XTE 1 JRNL REVDAT 1 22-APR-20 6XTE 0 JRNL AUTH C.SWALE,B.DA COSTA,L.SEDANO,F.GARZONI,A.A.MCCARTHY,I.BERGER, JRNL AUTH 2 C.BIENIOSSEK,R.W.H.RUIGROK,B.DELMAS,T.CREPIN JRNL TITL X-RAY STRUCTURE OF THE HUMAN KARYOPHERIN RANBP5, AN JRNL TITL 2 ESSENTIAL FACTOR FOR INFLUENZA POLYMERASE NUCLEAR JRNL TITL 3 TRAFFICKING. JRNL REF J.MOL.BIOL. V. 432 3353 2020 JRNL REFN ESSN 1089-8638 JRNL PMID 32222384 JRNL DOI 10.1016/J.JMB.2020.03.021 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 67.1 REMARK 3 NUMBER OF REFLECTIONS : 41396 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2155 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.45 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 6.78 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2322 REMARK 3 BIN FREE R VALUE : 0.2586 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 42 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8456 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 3 REMARK 3 SOLVENT ATOMS : 84 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 71.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.60760 REMARK 3 B22 (A**2) : -8.00980 REMARK 3 B33 (A**2) : -0.59780 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.540 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.299 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.563 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.305 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8645 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 11711 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3051 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1482 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8645 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1131 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6847 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.76 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.34 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|20 - A|450 } REMARK 3 ORIGIN FOR THE GROUP (A): -8.5573 3.3549 69.86 REMARK 3 T TENSOR REMARK 3 T11: -0.0431 T22: -0.0942 REMARK 3 T33: -0.0609 T12: -0.0102 REMARK 3 T13: 0.0258 T23: 0.0295 REMARK 3 L TENSOR REMARK 3 L11: 0.2264 L22: 0.8459 REMARK 3 L33: 1.1757 L12: 0.0619 REMARK 3 L13: 0.3943 L23: -0.3411 REMARK 3 S TENSOR REMARK 3 S11: 0.04 S12: -0.0717 S13: 0.1846 REMARK 3 S21: -0.0717 S22: 0.0266 S23: 0.0486 REMARK 3 S31: 0.1846 S32: 0.0486 S33: -0.0666 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|451 - A|800 } REMARK 3 ORIGIN FOR THE GROUP (A): 6.0331 35.6616 61.8948 REMARK 3 T TENSOR REMARK 3 T11: 0.0752 T22: -0.1441 REMARK 3 T33: -0.1519 T12: 0.0345 REMARK 3 T13: -0.031 T23: -0.0628 REMARK 3 L TENSOR REMARK 3 L11: 2.0642 L22: 1.1987 REMARK 3 L33: 0.4133 L12: -0.984 REMARK 3 L13: 0.4036 L23: -0.125 REMARK 3 S TENSOR REMARK 3 S11: -0.2988 S12: 0.2897 S13: 0.0718 REMARK 3 S21: 0.2897 S22: 0.2454 S23: -0.0939 REMARK 3 S31: 0.0718 S32: -0.0939 S33: 0.0534 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { A|801 - A|1115 } REMARK 3 ORIGIN FOR THE GROUP (A): 37.0044 13.6323 41.8226 REMARK 3 T TENSOR REMARK 3 T11: 0.0656 T22: -0.1845 REMARK 3 T33: -0.0579 T12: -0.0135 REMARK 3 T13: -0.0396 T23: -0.0457 REMARK 3 L TENSOR REMARK 3 L11: 0.8094 L22: 1.0941 REMARK 3 L33: 0.9323 L12: 0.3818 REMARK 3 L13: -0.4667 L23: -0.3531 REMARK 3 S TENSOR REMARK 3 S11: -0.1022 S12: 0.0228 S13: -0.0441 REMARK 3 S21: 0.0228 S22: 0.0418 S23: -0.0326 REMARK 3 S31: -0.0441 S32: -0.0326 S33: 0.0604 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6XTE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1292106192. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41396 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 48.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 70.3 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 14.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.89200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3W3U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRI-SODIUM CITRATE PH 4.5, 12 % REMARK 280 PEG 6000, 100 MM AMMONIUM ACETATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.54550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.48950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.15650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.48950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.54550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.15650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 47640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ANTIPAIN IS OLIGOPEPTIDE, A MEMBER OF ENZYME INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ANTIPAIN REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 335 REMARK 465 ASP A 336 REMARK 465 GLU A 337 REMARK 465 ASP A 338 REMARK 465 TRP A 339 REMARK 465 ALA A 340 REMARK 465 ASN A 341 REMARK 465 ALA A 342 REMARK 465 ASP A 343 REMARK 465 GLU A 344 REMARK 465 LEU A 345 REMARK 465 GLU A 346 REMARK 465 ASP A 347 REMARK 465 ASP A 348 REMARK 465 ASN A 610 REMARK 465 ASP A 611 REMARK 465 MET A 612 REMARK 465 GLU A 613 REMARK 465 ASP A 614 REMARK 465 ASP A 615 REMARK 465 ASP A 616 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 161 CG CD OE1 NE2 REMARK 470 GLN A 200 CG CD OE1 NE2 REMARK 470 ASP A 201 CG OD1 OD2 REMARK 470 GLU A 203 CG CD OE1 OE2 REMARK 470 LYS A 230 CG CD CE NZ REMARK 470 PHE A 350 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 606 CG CD OE1 NE2 REMARK 470 THR A 607 OG1 CG2 REMARK 470 ASP A 608 CG OD1 OD2 REMARK 470 PHE A 609 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 661 CG CD1 CD2 REMARK 470 GLN A 664 CG CD OE1 NE2 REMARK 470 MET A 666 CG SD CE REMARK 470 ASN A 668 CG OD1 ND2 REMARK 470 LYS A 689 CG CD CE NZ REMARK 470 GLU A 809 CG CD OE1 OE2 REMARK 470 GLU A 810 CG CD OE1 OE2 REMARK 470 GLU A 982 CG CD OE1 OE2 REMARK 470 GLU A1067 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL C 3 O - C - N ANGL. DEV. = -31.9 DEGREES REMARK 500 RGL C 4 C - N - CA ANGL. DEV. = 33.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 91 70.89 -155.90 REMARK 500 VAL A 95 -66.46 -98.86 REMARK 500 LEU A 138 51.94 -113.50 REMARK 500 SER A 160 139.24 -29.08 REMARK 500 ILE A 179 4.61 -62.65 REMARK 500 HIS A 186 -44.71 -152.21 REMARK 500 ASP A 201 78.82 -58.41 REMARK 500 GLU A 223 -37.56 -36.86 REMARK 500 TYR A 248 20.74 -74.53 REMARK 500 VAL A 265 59.73 -141.45 REMARK 500 HIS A 272 45.51 -140.50 REMARK 500 ALA A 308 51.41 -150.75 REMARK 500 LEU A 333 -95.25 -94.46 REMARK 500 GLU A 542 -132.12 55.37 REMARK 500 ALA A 563 38.99 -99.06 REMARK 500 GLN A 638 -38.14 -39.47 REMARK 500 LEU A 660 -118.33 -129.84 REMARK 500 LEU A 661 175.98 67.37 REMARK 500 ASP A 662 -129.73 -94.09 REMARK 500 THR A 663 -78.26 -66.84 REMARK 500 ASP A 665 -33.67 -152.69 REMARK 500 ASP A 673 -22.29 72.73 REMARK 500 ASN A 679 86.76 -66.68 REMARK 500 GLN A 683 -2.46 62.95 REMARK 500 LEU A 710 47.13 -109.50 REMARK 500 LYS A 872 -144.15 54.38 REMARK 500 HIS A1021 -25.81 -152.84 REMARK 500 GLU A1062 39.65 -76.29 REMARK 500 HIS A1071 -110.85 -70.85 REMARK 500 VAL C 3 163.61 9.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL C 3 RGL C 4 -127.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 VAL C 3 37.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1384 DISTANCE = 5.97 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1203 DBREF 6XTE A 22 1115 UNP O00410 IPO5_HUMAN 4 1097 DBREF 6XTE C 1 4 PDB 6XTE 6XTE 1 4 SEQADV 6XTE ALA A 20 UNP O00410 EXPRESSION TAG SEQADV 6XTE MET A 21 UNP O00410 EXPRESSION TAG SEQRES 1 A 1096 ALA MET ALA ALA ALA GLU GLN GLN GLN PHE TYR LEU LEU SEQRES 2 A 1096 LEU GLY ASN LEU LEU SER PRO ASP ASN VAL VAL ARG LYS SEQRES 3 A 1096 GLN ALA GLU GLU THR TYR GLU ASN ILE PRO GLY GLN SER SEQRES 4 A 1096 LYS ILE THR PHE LEU LEU GLN ALA ILE ARG ASN THR THR SEQRES 5 A 1096 ALA ALA GLU GLU ALA ARG GLN MET ALA ALA VAL LEU LEU SEQRES 6 A 1096 ARG ARG LEU LEU SER SER ALA PHE ASP GLU VAL TYR PRO SEQRES 7 A 1096 ALA LEU PRO SER ASP VAL GLN THR ALA ILE LYS SER GLU SEQRES 8 A 1096 LEU LEU MET ILE ILE GLN MET GLU THR GLN SER SER MET SEQRES 9 A 1096 ARG LYS LYS VAL CYS ASP ILE ALA ALA GLU LEU ALA ARG SEQRES 10 A 1096 ASN LEU ILE ASP GLU ASP GLY ASN ASN GLN TRP PRO GLU SEQRES 11 A 1096 GLY LEU LYS PHE LEU PHE ASP SER VAL SER SER GLN ASN SEQRES 12 A 1096 VAL GLY LEU ARG GLU ALA ALA LEU HIS ILE PHE TRP ASN SEQRES 13 A 1096 PHE PRO GLY ILE PHE GLY ASN GLN GLN GLN HIS TYR LEU SEQRES 14 A 1096 ASP VAL ILE LYS ARG MET LEU VAL GLN CYS MET GLN ASP SEQRES 15 A 1096 GLN GLU HIS PRO SER ILE ARG THR LEU SER ALA ARG ALA SEQRES 16 A 1096 THR ALA ALA PHE ILE LEU ALA ASN GLU HIS ASN VAL ALA SEQRES 17 A 1096 LEU PHE LYS HIS PHE ALA ASP LEU LEU PRO GLY PHE LEU SEQRES 18 A 1096 GLN ALA VAL ASN ASP SER CYS TYR GLN ASN ASP ASP SER SEQRES 19 A 1096 VAL LEU LYS SER LEU VAL GLU ILE ALA ASP THR VAL PRO SEQRES 20 A 1096 LYS TYR LEU ARG PRO HIS LEU GLU ALA THR LEU GLN LEU SEQRES 21 A 1096 SER LEU LYS LEU CYS GLY ASP THR SER LEU ASN ASN MET SEQRES 22 A 1096 GLN ARG GLN LEU ALA LEU GLU VAL ILE VAL THR LEU SER SEQRES 23 A 1096 GLU THR ALA ALA ALA MET LEU ARG LYS HIS THR ASN ILE SEQRES 24 A 1096 VAL ALA GLN THR ILE PRO GLN MET LEU ALA MET MET VAL SEQRES 25 A 1096 ASP LEU GLU GLU ASP GLU ASP TRP ALA ASN ALA ASP GLU SEQRES 26 A 1096 LEU GLU ASP ASP ASP PHE ASP SER ASN ALA VAL ALA GLY SEQRES 27 A 1096 GLU SER ALA LEU ASP ARG MET ALA CYS GLY LEU GLY GLY SEQRES 28 A 1096 LYS LEU VAL LEU PRO MET ILE LYS GLU HIS ILE MET GLN SEQRES 29 A 1096 MET LEU GLN ASN PRO ASP TRP LYS TYR ARG HIS ALA GLY SEQRES 30 A 1096 LEU MET ALA LEU SER ALA ILE GLY GLU GLY CYS HIS GLN SEQRES 31 A 1096 GLN MET GLU GLY ILE LEU ASN GLU ILE VAL ASN PHE VAL SEQRES 32 A 1096 LEU LEU PHE LEU GLN ASP PRO HIS PRO ARG VAL ARG TYR SEQRES 33 A 1096 ALA ALA CYS ASN ALA VAL GLY GLN MET ALA THR ASP PHE SEQRES 34 A 1096 ALA PRO GLY PHE GLN LYS LYS PHE HIS GLU LYS VAL ILE SEQRES 35 A 1096 ALA ALA LEU LEU GLN THR MET GLU ASP GLN GLY ASN GLN SEQRES 36 A 1096 ARG VAL GLN ALA HIS ALA ALA ALA ALA LEU ILE ASN PHE SEQRES 37 A 1096 THR GLU ASP CYS PRO LYS SER LEU LEU ILE PRO TYR LEU SEQRES 38 A 1096 ASP ASN LEU VAL LYS HIS LEU HIS SER ILE MET VAL LEU SEQRES 39 A 1096 LYS LEU GLN GLU LEU ILE GLN LYS GLY THR LYS LEU VAL SEQRES 40 A 1096 LEU GLU GLN VAL VAL THR SER ILE ALA SER VAL ALA ASP SEQRES 41 A 1096 THR ALA GLU GLU LYS PHE VAL PRO TYR TYR ASP LEU PHE SEQRES 42 A 1096 MET PRO SER LEU LYS HIS ILE VAL GLU ASN ALA VAL GLN SEQRES 43 A 1096 LYS GLU LEU ARG LEU LEU ARG GLY LYS THR ILE GLU CYS SEQRES 44 A 1096 ILE SER LEU ILE GLY LEU ALA VAL GLY LYS GLU LYS PHE SEQRES 45 A 1096 MET GLN ASP ALA SER ASP VAL MET GLN LEU LEU LEU LYS SEQRES 46 A 1096 THR GLN THR ASP PHE ASN ASP MET GLU ASP ASP ASP PRO SEQRES 47 A 1096 GLN ILE SER TYR MET ILE SER ALA TRP ALA ARG MET CYS SEQRES 48 A 1096 LYS ILE LEU GLY LYS GLU PHE GLN GLN TYR LEU PRO VAL SEQRES 49 A 1096 VAL MET GLY PRO LEU MET LYS THR ALA SER ILE LYS PRO SEQRES 50 A 1096 GLU VAL ALA LEU LEU ASP THR GLN ASP MET GLU ASN MET SEQRES 51 A 1096 SER ASP ASP ASP GLY TRP GLU PHE VAL ASN LEU GLY ASP SEQRES 52 A 1096 GLN GLN SER PHE GLY ILE LYS THR ALA GLY LEU GLU GLU SEQRES 53 A 1096 LYS SER THR ALA CYS GLN MET LEU VAL CYS TYR ALA LYS SEQRES 54 A 1096 GLU LEU LYS GLU GLY PHE VAL GLU TYR THR GLU GLN VAL SEQRES 55 A 1096 VAL LYS LEU MET VAL PRO LEU LEU LYS PHE TYR PHE HIS SEQRES 56 A 1096 ASP GLY VAL ARG VAL ALA ALA ALA GLU SER MET PRO LEU SEQRES 57 A 1096 LEU LEU GLU CYS ALA ARG VAL ARG GLY PRO GLU TYR LEU SEQRES 58 A 1096 THR GLN MET TRP HIS PHE MET CYS ASP ALA LEU ILE LYS SEQRES 59 A 1096 ALA ILE GLY THR GLU PRO ASP SER ASP VAL LEU SER GLU SEQRES 60 A 1096 ILE MET HIS SER PHE ALA LYS CYS ILE GLU VAL MET GLY SEQRES 61 A 1096 ASP GLY CYS LEU ASN ASN GLU HIS PHE GLU GLU LEU GLY SEQRES 62 A 1096 GLY ILE LEU LYS ALA LYS LEU GLU GLU HIS PHE LYS ASN SEQRES 63 A 1096 GLN GLU LEU ARG GLN VAL LYS ARG GLN ASP GLU ASP TYR SEQRES 64 A 1096 ASP GLU GLN VAL GLU GLU SER LEU GLN ASP GLU ASP ASP SEQRES 65 A 1096 ASN ASP VAL TYR ILE LEU THR LYS VAL SER ASP ILE LEU SEQRES 66 A 1096 HIS SER ILE PHE SER SER TYR LYS GLU LYS VAL LEU PRO SEQRES 67 A 1096 TRP PHE GLU GLN LEU LEU PRO LEU ILE VAL ASN LEU ILE SEQRES 68 A 1096 CSO PRO HIS ARG PRO TRP PRO ASP ARG GLN TRP GLY LEU SEQRES 69 A 1096 CYS ILE PHE ASP ASP VAL ILE GLU HIS CYS SER PRO ALA SEQRES 70 A 1096 SER PHE LYS TYR ALA GLU TYR PHE LEU ARG PRO MET LEU SEQRES 71 A 1096 GLN TYR VAL CYS ASP ASN SER PRO GLU VAL ARG GLN ALA SEQRES 72 A 1096 ALA ALA TYR GLY LEU GLY VAL MET ALA GLN TYR GLY GLY SEQRES 73 A 1096 ASP ASN TYR ARG PRO PHE CYS THR GLU ALA LEU PRO LEU SEQRES 74 A 1096 LEU VAL ARG VAL ILE GLN SER ALA ASP SER LYS THR LYS SEQRES 75 A 1096 GLU ASN VAL ASN ALA THR GLU ASN CYS ILE SER ALA VAL SEQRES 76 A 1096 GLY LYS ILE MET LYS PHE LYS PRO ASP CYS VAL ASN VAL SEQRES 77 A 1096 GLU GLU VAL LEU PRO HIS TRP LEU SER TRP LEU PRO LEU SEQRES 78 A 1096 HIS GLU ASP LYS GLU GLU ALA VAL GLN THR PHE ASN TYR SEQRES 79 A 1096 LEU CYS ASP LEU ILE GLU SER ASN HIS PRO ILE VAL LEU SEQRES 80 A 1096 GLY PRO ASN ASN THR ASN LEU PRO LYS ILE PHE SER ILE SEQRES 81 A 1096 ILE ALA GLU GLY GLU MET HIS GLU ALA ILE LYS HIS GLU SEQRES 82 A 1096 ASP PRO CYS ALA LYS ARG LEU ALA ASN VAL VAL ARG GLN SEQRES 83 A 1096 VAL GLN THR SER GLY GLY LEU TRP THR GLU CYS ILE ALA SEQRES 84 A 1096 GLN LEU SER PRO GLU GLN GLN ALA ALA ILE GLN GLU LEU SEQRES 85 A 1096 LEU ASN SER ALA SEQRES 1 C 4 FC0 ARG VAL RGL MODRES 6XTE CSO A 891 CYS MODIFIED RESIDUE HET CSO A 891 7 HET FC0 C 1 13 HET RGL C 4 11 HET NI A1201 1 HET NI A1202 1 HET CL A1203 1 HETNAM CSO S-HYDROXYCYSTEINE HETNAM FC0 N-CARBOXY-L-PHENYLALANINE HETNAM RGL ARGINAL HETNAM NI NICKEL (II) ION HETNAM CL CHLORIDE ION FORMUL 1 CSO C3 H7 N O3 S FORMUL 2 FC0 C10 H11 N O4 FORMUL 2 RGL C6 H15 N4 O 1+ FORMUL 3 NI 2(NI 2+) FORMUL 5 CL CL 1- FORMUL 6 HOH *84(H2 O) HELIX 1 AA1 MET A 21 LEU A 37 1 17 HELIX 2 AA2 ASP A 40 ASN A 53 1 14 HELIX 3 AA3 PRO A 55 ASN A 69 1 15 HELIX 4 AA4 ALA A 73 ALA A 91 1 19 HELIX 5 AA5 ALA A 91 TYR A 96 1 6 HELIX 6 AA6 PRO A 100 GLU A 118 1 19 HELIX 7 AA7 GLN A 120 ASN A 137 1 18 HELIX 8 AA8 TRP A 147 SER A 160 1 14 HELIX 9 AA9 ASN A 162 PHE A 176 1 15 HELIX 10 AB1 TYR A 187 ASP A 201 1 15 HELIX 11 AB2 PRO A 205 ALA A 221 1 17 HELIX 12 AB3 ASN A 225 PHE A 232 1 8 HELIX 13 AB4 LEU A 235 TYR A 248 1 14 HELIX 14 AB5 ASP A 252 VAL A 265 1 14 HELIX 15 AB6 PRO A 266 PRO A 271 5 6 HELIX 16 AB7 HIS A 272 GLY A 285 1 14 HELIX 17 AB8 ASN A 290 ALA A 308 1 19 HELIX 18 AB9 ALA A 308 ARG A 313 1 6 HELIX 19 AC1 HIS A 315 ASP A 332 1 18 HELIX 20 AC2 SER A 352 GLY A 369 1 18 HELIX 21 AC3 GLY A 369 GLN A 386 1 18 HELIX 22 AC4 ASP A 389 ILE A 403 1 15 HELIX 23 AC5 ILE A 403 HIS A 408 1 6 HELIX 24 AC6 ILE A 414 PHE A 425 1 12 HELIX 25 AC7 LEU A 426 ASP A 428 5 3 HELIX 26 AC8 HIS A 430 PHE A 448 1 19 HELIX 27 AC9 PRO A 450 ASP A 470 1 21 HELIX 28 AD1 ASN A 473 ASP A 490 1 18 HELIX 29 AD2 PRO A 492 ILE A 497 1 6 HELIX 30 AD3 TYR A 499 LYS A 521 1 23 HELIX 31 AD4 LYS A 524 GLU A 542 1 19 HELIX 32 AD5 GLU A 543 PRO A 547 5 5 HELIX 33 AD6 TYR A 548 ALA A 563 1 16 HELIX 34 AD7 GLN A 565 GLU A 567 5 3 HELIX 35 AD8 LEU A 568 GLY A 587 1 20 HELIX 36 AD9 GLY A 587 ASP A 608 1 22 HELIX 37 AE1 GLN A 618 GLY A 634 1 17 HELIX 38 AE2 LYS A 635 GLN A 639 5 5 HELIX 39 AE3 TYR A 640 SER A 653 1 14 HELIX 40 AE4 LEU A 680 GLN A 684 5 5 HELIX 41 AE5 GLY A 692 LEU A 710 1 19 HELIX 42 AE6 LEU A 710 VAL A 715 1 6 HELIX 43 AE7 TYR A 717 VAL A 726 1 10 HELIX 44 AE8 PRO A 727 PHE A 731 5 5 HELIX 45 AE9 HIS A 734 GLY A 756 1 23 HELIX 46 AF1 GLY A 756 GLY A 776 1 21 HELIX 47 AF2 ASP A 780 GLY A 799 1 20 HELIX 48 AF3 ASN A 804 ARG A 833 1 30 HELIX 49 AF4 ASP A 839 LYS A 872 1 34 HELIX 50 AF5 VAL A 875 GLU A 880 1 6 HELIX 51 AF6 LEU A 882 ILE A 890 1 9 HELIX 52 AF7 PRO A 895 CYS A 913 1 19 HELIX 53 AF8 PRO A 915 TYR A 923 5 9 HELIX 54 AF9 PHE A 924 VAL A 932 1 9 HELIX 55 AG1 SER A 936 GLY A 954 1 19 HELIX 56 AG2 GLY A 955 ASN A 957 5 3 HELIX 57 AG3 TYR A 958 SER A 975 1 18 HELIX 58 AG4 ASN A 983 LYS A 1001 1 19 HELIX 59 AG5 PRO A 1002 VAL A 1005 5 4 HELIX 60 AG6 ASN A 1006 LEU A 1018 1 13 HELIX 61 AG7 ASP A 1023 SER A 1040 1 18 HELIX 62 AG8 PRO A 1043 THR A 1051 5 9 HELIX 63 AG9 ASN A 1052 GLU A 1062 1 11 HELIX 64 AH1 PRO A 1074 GLN A 1087 1 14 HELIX 65 AH2 SER A 1089 GLN A 1099 1 11 HELIX 66 AH3 SER A 1101 ALA A 1115 1 15 SHEET 1 AA1 3 VAL A 658 ALA A 659 0 SHEET 2 AA1 3 PHE A 686 ILE A 688 -1 O GLY A 687 N ALA A 659 SHEET 3 AA1 3 GLU A 676 VAL A 678 -1 N GLU A 676 O ILE A 688 LINK C ILE A 890 N CSO A 891 1555 1555 1.35 LINK C CSO A 891 N PRO A 892 1555 1555 1.34 LINK C1 FC0 C 1 N ARG C 2 1555 1555 1.41 LINK C VAL C 3 N RGL C 4 1555 1555 1.37 CISPEP 1 ALA A 449 PRO A 450 0 -1.94 CISPEP 2 SER A 914 PRO A 915 0 3.59 CISPEP 3 LEU A 1018 PRO A 1019 0 6.97 SITE 1 AC1 3 CYS A 802 ASN A 804 HIS A 807 SITE 1 AC2 3 ARG A 68 GLN A 974 TRP A1017 SITE 1 AC3 2 HIS A 394 ARG A 432 CRYST1 87.091 96.313 156.979 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011482 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010383 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006370 0.00000